Status:
NOT_YET_RECRUITING
Oxygen Therapy in Diabetic Kidney Disease
Lead Sponsor:
Assiut University
Conditions:
Diabetic Kidney Disease
Eligibility:
All Genders
10-17 years
Phase:
NA
Brief Summary
Diabetic kidney disease (DKD) is the most significant cause of end-stage kidney disease (ESKD). Albuminuria, evolving from microalbuminuria to nephrotic-range proteinuria, is a clinical hallmark of di...
Detailed Description
According to the International Diabetes Federation's report, over 530 million people worldwide have diabetes . About one-third of diabetic patients develop diabetic nephropathy (DN) after the incubati...
Eligibility Criteria
Inclusion
- \- Diabetic male and female patients aged \> 18 yrs with diabetic kidney disease (eGFR 30-90 mL/min/1.73m² and proteinuria \>300 mg/day)
Exclusion
- Age \< 18 yrs
- Cardiovascular disease (thorough assessment of the patient's medical history (symptoms suggestive of CVD (e.g., chest pain, shortness of breath, fatigue), family history of CVD and risk factors (e.g., hypertension, hyperlipidemia, smoking). Physical Examination including blood pressure measurement, auscultation of heart sounds and assessment of peripheral pulses. Additional Diagnostic Tests: Stress test (stress ECG and stress echocardiography): Evaluate cardiac function under stress, which can help detect coronary artery disease or other CVD.
- Chronic lung disease (COPD, pulmonary fibrosis …
- Other chronic disease affecting kidney function (lupus nephritis).
- Pregnancy or lactation.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 10 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06959485
Start Date
August 1 2025
End Date
August 10 2026
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University hospitals
Asyut, Egypt